Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers
RATIONALE: A disease management program may be more effective than standard therapy in improving quality of life and controlling symptoms in patients with cancer. PURPOSE: This clinical trial is studying a disease management program to see how well it works compared with usual care in patients with stage III or stage IV lung cancer, stage III or stage IV pancreatic cancer, stage III or stage IV ovarian cancer, or stage III or stage IV colorectal cancer, and their caregivers.
Checked against the public recordLast updated Oct 9, 2015 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Case Comprehensive Cancer Center
- Interventions being studied
- Other: questionnaire administration; Procedure: quality-of-life assessment
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
DISEASE CHARACTERISTICS: * Histologically confirmed diagnosis of 1 of the following: * Lung cancer * Pancreatic cancer * Ovarian cancer * Colorectal cancer * Stage III or IV disease * Receiving care at the Ireland Cancer Center PATIENT CHARACTERISTICS: * ECOG performance status 0-3 * Life expectancy ≥ 3 months * No cognitive impairment * May not transfer care out of geographic area * Must have caregiver available to participate PRIOR CONCURRENT THERAPY: * Not specified
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer CenterCleveland, Ohio
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 9, 2015. Always confirm current availability with the study team.